Report title: Synthetic Blood Corporation - Portfolio Company Report
from Thomson Financial Venture Economics
published Jun 06, 2009

Price $24.00 available for immediate download
Report Overview
 
About Thomson Financial Venture Econ...

Developing a synthetic blood product for the direct replacement of human blood, blood plasma and volume extenders. It can also be used as a drug delivery system for oil-based drugs. The product is a sterile, water-based system consisting of two liquids which, when combined, have the physical and chemical properties of human blood. It can maintain or restore normal circulating volume and blood pressure for a transfusion. It has the same physiological range as human blood and merges with the existing blood system. Currently, the product is being tested in animals. ; Develops synthetic blood product for the direct replacement of human blood.

Report Type: This research report shows venture capital financing information for this specific company.
Executives Listed: 1
Number of Investing Funds: 5
Free Sample: Click Here to Download
Format:
PDF Adobe Acrobat


Price: $24.00



  Can't Decide?

Purchasing premium research sight unseen can be intimidating. At Alacra we want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.